Safety and effectiveness of SGM-101, a fluorescent antibody targeting carcinoembryonic antigen, for intraoperative detection of colorectal cancer: a dose-escalation pilot study

Author(s):
Boogerd, L.S.F.; Hoogstins, C.E.S.; Schaap, D.P.; Kusters, M.; Handgraaf, H.J.M.; Valk, M.J.M. van der; Hilling, D.E.; Holman, F.A.; Peeters, K.C.M.J.; Mieog, J.S.D.; Velde, C.J.H.V. de; Farina-Sarasqueta, A.; Lijnschoten, I. van; Framery, B.; Pelegrin, A.; Gutowski, M.; Nienhuijs, S.W.; Hingh, I.H.J.T. de; Nieuwenhuijzen, G.A.P.; Rutten, H.J.T.; Cailler, F.; Burggraaf, J.; Vahrmeijer, A.L.
Published
2018
Publication type
Article / Letter to editor
Date issued
2018-03-31
Language
English
Is part of
The Lancet Gastroenterology and Hepatology (2018), Vol. 3, no. 3, p. 181-191
hdl
1887/94550
doi
10.1016/S2468-1253(17)30395-3